Theravance Biopharma, Inc.
TBPH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $4 | $55 | -$14 | -$16 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $1 | -$11 | -$2 | -$7 |
| Stock-Based Comp. | $0 | $5 | $5 | $6 |
| Change in WC | -$17 | $158 | $52 | $14 |
| Other Non-Cash | $4 | $1 | $1 | $1 |
| Operating Cash Flow | -$7 | $208 | $43 | -$1 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | $0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$125 | -$57 | -$2 | -$40 |
| Inv. Sales/Matur. | $25 | $20 | $33 | $56 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$100 | -$36 | $31 | $16 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$1 | -$1 | -$1 | -$1 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | -$0 | -$1 | -$1 | -$0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$107 | $171 | $73 | $14 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $282 | $111 | $39 | $24 |
| End Cash | $175 | $283 | $111 | $39 |
| Free Cash Flow | -$7 | $208 | $43 | -$1 |